+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
End-Stage Renal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

End-Stage Renal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Menopausal Therapy Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Menopausal Therapy Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
ECOA, ESource and Clinical Trials Market Report 2025 - Product Thumbnail Image

ECOA, ESource and Clinical Trials Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Menopausal Hot Flashes Market Report 2025 - Product Thumbnail Image

Menopausal Hot Flashes Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Menopause Market Report 2025 - Product Thumbnail Image

Menopause Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Injectable Drug Delivery Devices Market Report 2025 - Product Thumbnail Image

Injectable Drug Delivery Devices Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Loading Indicator